Grant: $313,200 - Department of Health and Human Services - Sep. 28, 2009
100% voted satisfied - 0% voted not satisfied - 1 vote(s) cast
Award Description: This study develops novel approaches based on the p14ARF tumor suppressor and Spermidine-CoA-based inhibitors of histone acetylation to improve cellular responses to topoisomerase I-targeted chemotherapies and reverse therapy resistance, a major obstacle to successful cancer treatment. The study also develops diagnostic tools for identifying therapy responsive tumors and optimizing therapeutic regimens.
Project Description: The start date of this project period is also the last day of the reporting period (9/30/09). Therefore, work on the project had not started during the period covered by this report.
Infrastructure Description: N/A
Jobs Summary: Not started. (Total jobs reported: 0)
Project Status: Not Started
This award's data was last updated on Sep. 28, 2009. Help expand these official descriptions using the wiki below.